| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Mai―24 |
COVID-19 AND POST COVID-19 AND THE EMERGENCE OF SLE AND EXACERBATIONS |
Yehuda Shoenfeld |
| 2 |
[GO] |
2025―Mai―20 |
SARS-COV-2 MRNA VACCINE IMMUNOGENICITY IN SLE |
Rebecca Sadun, Dan Crair, Sarah Valencia, Emmanuel Walter, M. Anthony Moody |
| 3 |
[GO] |
2025―Mai―20 |
SAFETY PROFILE OF VACCINES AGAINST SARS-COV-2 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM PROSPECTIVE MULTICENTRIC STUDY - SAFER STUDY |
Natália Sartori, Ketty Machado, Samira Miyamoto, Flavia Pretti, Maria Da Penha Gouveia, Yasmin Oliveira, Vanezia Da Silva, Filipe Faé, Ana Paula Burian, Karina Tapia, Anna Carolina Moulin, Luiza Grillo, Paula Athayde, Helena Corona, Sabrina Ramos, Flavia Maria Peixoto, Priscila Ribeiro, Vanessa Magalhães, Mariana De Aguiar, Erika Biegelmeyer, Cristiane Kayser, Alexandre Wagner De Souza, Charlles Castro, Juliana Bühring, Sandra Lúcia Ribeiro, Sérgio Henrique Dos Santos, Clara Martins, Jonathan Willian Rodrigues, Marcos Dias, Bruna Dutra, Camila Maria Telles, Samuel Elias Dias, Rodrigo De Rezende, Katia Baptista, Rodrigo Gaudio, Ana Karla De Melo, Valéria Da Silva, Vitor Cruz, Jozelia Rêgo, Rejane Maria Vieira, Adah Sophia Vieira, Adriana Maria Kakehasi, Anna Carolina Tavares, Victória Carvalho, Renata De Azevedo, Valderilio Azevedo, Olindo Martins-Filho, Vanessa Magalhães, Andrese Gasparin, Vanesssa Hax, Valéria Valim, Gilda Ferreira, Andréa Carvalho, Edgard Torres, Marcelo Pinheiro, Viviane De Souza, Ricardo Xavier, Gecilmara Pileggi, Emília Inoue Sato, Odirlei Andre Monticielo |
| 4 |
[GO] |
2025―Mai―20 |
PREDICTORS OF MECHANICAL VENTILATION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH CORONAVIRUS DISEASE 2019: INSIGHTS FROM NATIONAL INPATIENT DATA |
Godbless Ajenaghughrure, Sila Mateo Faxas, Tochukwu Ikpeze |
| 5 |
[GO] |
2025―Mai―20 |
CARDIOVASCULAR AND CEREBROVASCULAR OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH CORONAVIRUS DISEASE 2019: A NATIONAL INPATIENT ANALYSIS |
Sila Mateo Faxas, Godbless Ajenaghughrure, Nirys Mateo Faxas, Tochukwu Ikpeze, Mian Hammas, Kim Nguyen |
| 6 |
[GO] |
2025―Mai―20 |
RISK OF ACUTE KIDNEY INJURY IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH CORONAVIRUS DISEASE 2019: A NATIONAL INPATIENT ANALYSIS |
Sila Mateo Faxas, Godbless Ajenaghughrure, Nirys Mateo Faxas, Aavash Mishra, Tochukwu Ikpeze, Mian Hammas, Kim Nguyen |
| 7 |
[GO] |
2025―Mai―20 |
ANALYSIS OF RACIAL DISPARITIES IN CORONAVIRUS DISEASE 2019 OUTCOMES AMONG HOSPITALIZED SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: A NATIONAL INPATIENT STUDY |
Sila Mateo Faxas, Godbless Ajenaghughrure, Nirys Mateo Faxas, Tochukwu Ikpeze, Mian Hammas, Kim Nguyen |
| 8 |
[GO] |
2025―Mai―20 |
ECONOMIC IMPACT AND RESOURCE UTILIZATION OF CORONAVIRUS DISEASE 2019 IN HOSPITALIZED SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: A NATIONAL INPATIENT ANALYSIS |
Sila Mateo Faxas, Godbless Ajenaghughrure, Nirys Mateo Faxas, Tochukwu Ikpeze, Mian Hammas, Kim Nguyen |
| 9 |
[GO] |
2025―Mai―20 |
ANALYSIS OF PULMONARY COMPLICATIONS IN SLE PATIENTS WITH AND WITHOUT COVID-19: A NATIONAL INPATIENT STUDY |
Godbless Ajenaghughrure, Sila Mateo Faxas, Tochukwu Ikpeze |
| 10 |
[GO] |
2025―Mai―20 |
PROTEIN SUBUNIT AND MRNA COVID-19 VACCINES: COMPARATIVE STUDY ON INDUCED-IMMUNOGENICITY IN RITUXIMAB-TREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND VASCULITIS |
Paul R Fortin, Nathalie Amiable, Inés Colmegna, François Harel, Anne-Sophie Julien, Mehdi Benlarbi, Mathieu Dubé, Sonia Léger-Thériault, Alexandra Godbout, Gloria Delgado, Mélina Duchesne, Rose Cloutier, Josée Perreault, Annie Gravel, Lison Fournier, Giuliana Alfonso, Josiane Bourré-Tessier, Marie Hudson, Nicolas Richard, Jean-Paul Makhzoum, Arielle Mendel, Sasha Bernatsky, Marc Dionne, Michael Libman, Gaston De Serres, Mélanie Dieudé, Louis Flamand, Daniel Kaufmann, Andrés Finzi, Renée Bazin |
| 11 |
[GO] |
2025―Mai―20 |
THE COVID-19 PANDEMIC REDUCED STRESS DIFFERENTLY IN PEOPLE WITH LUPUS BY POVERTY AND SOCIAL ISOLATION |
S. Sam Lim, Chenyang Yuan, Gaobin Bao, Charmayne Dunlop-Thomas, Kirk Easley |
| 12 |
[GO] |
2025―Mai―20 |
COVID-19 IS ASSOCIATED WITH LUPUS FLARE AND PERSISTENT DISEASE ACTIVITY: LONGITUDINAL DATA FROM THE REUMACOV-BRAZIL REGISTER |
Joana De Carvalho, Edgard Torres, Adriana Kakehasi, Sandra Ribeiro, Samia Studart, Francielle Martins, Rafaela Espírito Santo, Aline Ranzolin, Diana Fernandino, Valquiria Dinis, Emilia Sato, Gustavo Resende, Adriana Marinho, Henrique Ataide Mariz, Nathalia Sacilotto, Francinne Machado Ribeiro, Samuel Shinjo, Laiza Dias, Michel Yazbek, Felipe Omura, Thiago Rached, Ana Paula Gomides, Cláudia Marques, Gecilmara Pileggi, Licia Maria Mota, Marcelo Pinheiro, Ricardo Xavier, Odirlei Andre Monticielo, Gilda Ferreira |
| 13 |
[GO] |
2025―Mai―20 |
COVID-19 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A SINGLE-CENTER EXPERIENCE |
Rowsan Ara, Zahid Alam, Rashedul Hassan, Mohammad Asifuzzaman, Syed Haq |
| 14 |
[GO] |
2025―Mai―20 |
COVID-19 BOOSTER VACCINATION, EITHER MRNA OR PROTEIN SUBUNIT VACCINES, APPEARS SAFE IN RITUXIMAB-TREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND VASCULITIS |
Paul R Fortin, Nathalie Amiable, Inés Colmegna, François Harel, Anne-Sophie Julien, Mehdi Benlarbi, Mathieu Dubé, Sonia Léger-Thériault, Alexandra Godbout, Gloria Delgado, Mélina Duchesne, Rose Cloutier, Josée Perreault, Annie Gravel, Lison Fournier, Giuliana Alfonso, Josiane Bourré-Tessier, Marie Hudson, Nicolas Richard, Jean-Paul Makhzoum, Arielle Mendel, Sasha Bernatsky, Marc Dionne, Michael Libman, Gaston De Serres, Mélanie Dieudé, Louis Flamand, Daniel Kaufmann, Andrés Finzi, Renée Bazin |
| 15 |
[GO] |
2024―Jul―01 |
Prevalence and Risk Factors of Post-Acute Sequela of COVID-19 in Adults with Systemic Autoimmune Rheumatic Diseases |
Mayan S. Teles, Janetta Brundage, Teresa Po-Yu Chiang, Jennifer L. Alejo, Nicolas Henriquez, Rachel Wallwork, Lisa Christopher Stine, Allan Massie, Dorry L. Segev, Caoilfhionn M. Connolly, Julie J. Paik, William A. Werbel |
| 16 |
[GO] |
2024―Apr―15 |
When Should I Get My Next COVID Vaccine? Data from the SUrveillance of responses to COVID-19 vaCcines in systEmic immunE mediated inflammatory Diseases (SUCCEED)study |
Dawn M.E. Bowdish, Vinod Chandran, Carol A. Hitchon, Gilaad G. Kaplan, J. Antonio Avina-Zubieta, Paul R. Fortin, Maggie J. Larché, Gilles Boire, Anne-Claude Gingras, Roya M. Dayam, Ines Colmegna, Luck Lukusa, Jennifer L.F. Lee, Dawn P. Richards, Daniel Pereira, Tania H. Watts, Mark S. Silverberg, Charles N. Bernstein, Diane Lacaille, Jenna Benoit, John Kim, Nadine Lalonde, Janet Gunderson, Hugues Allard-Chamard, Sophie Roux, Joshua Quan, Lindsay Hracs, Elizabeth Turnbull, Valeria Valerio, Sasha Bernatsky |
| 17 |
[GO] |
2024―Mrz―01 |
Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease |
Naomi J. Patel, Xiaosong Wang, Miao Lin, Emily N. Kowalski, Claire E. Cook, Kathleen M.M. Vanni, Krishan Guzzo, Grace Qian, Katarina J. Bade, Alene Saavedra, Rathnam Venkat, Shruthi Srivatsan, Zachary K. Williams, Jennifer S. Hanberg, Yumeko Kawano, Abigail E. Schiff, Jeffrey A. Sparks, Zachary S. Wallace |
| 18 |
[GO] |
2024―Feb―01 |
Psoriatic Arthritis and COVID-19 |
Hinpetch Daungsupawong, Viroj Wiwanitkit |
| 19 |
[GO] |
2024―Feb―01 |
Additional Reassuring Data for SARS-CoV-2 Vaccination in Immune-Mediated Inflammatory Diseases, but With a Catch |
Alfred H.J. Kim |
| 20 |
[GO] |
2024―Jan―15 |
The Future of COVID-19 for Patients With Immune-Mediated Inflammatory Diseases: Who Is at Risk? |
Cassandra Calabrese |
| 21 |
[GO] |
2024―Jan―15 |
Role of Creation of Plain Language Summaries to Disseminate COVID-19 Research Findings to Patients With Rheumatic Diseases |
Mithu Maheswaranathan, Akpabio Akpabio, Laura-Ann Tomasella, Ariella Coler-Reilly, Dawn P. Richards, Richard A. Howard, Monique Gore-Massy, Nadine Ladone, Emily Sirotich |
| 22 |
[GO] |
2023―Okt―15 |
Breakthrough COVID-19 after tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases |
Yumeko Kawano, Xiaosong Wang, Naomi J. Patel, Grace Qian, Emily Kowalski, Katarina J. Bade, Kathleen M.M. Vanni, A. Helena Jonsson, Zachary K. Williams, Shruthi Srivatsan, Claire E. Cook, Zachary S. Wallace, Jeffrey A. Sparks |
| 23 |
[GO] |
2023―Okt―01 |
Safety and Health Care Utilization following COVID-19 Vaccination among Adults with Rheumatoid Arthritis - A population-based self-controlled case series analysis |
Jennifer J. Y. Lee, Sasha Bernatsky, Jeffrey C. Kwong, Qing Li, Timothy S. H. Kwok, Jessica Widdifield |
| 24 |
[GO] |
2023―Sep―01 |
Psoriatic Arthritis And Covid-19 - Patient Perspectives In A Large Psoriatic Arthritis Cohort |
Neda Pirouzmand, Daniel Pereira, Mitchell Sutton, Ashish J. Mathew, Vinod Chandran, Dafna D. Gladman |
| 25 |
[GO] |
2023―Aug―01 |
Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis |
Philip J. Mease, Peter Nash, Suzanne Grieb, Vinod Chandran |
| 26 |
[GO] |
2023―Jul―15 |
Sex in the Time of COVID-19 |
Mark Harrison |
| 27 |
[GO] |
2023―Jun―15 |
The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort |
Philippa D.K. Curry, Hector Chinoy, Meghna Jani, Darren Plant, Kimmie L. Hyrich, Ann W. Morgan, A.G. Wilson, John D. Isaacs, Andrew P. Morris, Anne Barton, James Bluett |
| 28 |
[GO] |
2023―Mai―01 |
Molnupiravir and Nirmatelvir/Ritonavir in the Treatment of Patients With Systemic Autoimmune Rheumatic Disease With SARS-CoV-2 |
Kelly Corbitt, Peter Izmirly, Amit Saxena |
| 29 |
[GO] |
2023―Mrz―15 |
Biologic sex inequality in rheumatology wait times during the COVID-19 pandemic |
Steven J. Katz, Carrie Ye |
| 30 |
[GO] |
2023―Mrz―15 |
COVID-19 Vaccination as a Trigger of IgA Vasculitis: Truth or Illusion? |
Gang Wang, Ying Luo, Bihui Li, Jie Li |
| 31 |
[GO] |
2023―Feb―01 |
Importance of SARS-CoV-2 Spike Antibodies and B Cell Reconstitution to Optimize the Prevention Strategy of COVID-19 |
Marion Thomas, Jérôme Avouac |
| 32 |
[GO] |
2023―Jan―15 |
Preferences for COVID-19 vaccination in people with chronic immune-mediated inflammatory diseases |
Glen S. Hazlewood, Ines Colmegna, Carol Hitchon, Paul R. Fortin, Sasha Bernatsk, Ann E. Clarke, Dianne Mosher, Todd Wilson, Megan Thomas, Claire Barber, Mark Harrison, Nick Bansback, Laurie Proulx, Dawn P. Richards, Gilaad G. Kaplan |
| 33 |
[GO] |
2023―Jan―15 |
Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines against COVID-19 infection among patients with systemic autoimmune rheumatic diseases on immunomodulatory medications |
Claire Cook, Naomi J. Patel, Xiaoqing Fu, Xiaosong Wang, Yumeko Kawano, Kathleen M.M. Vanni, Grace Qian, Emily Banasiak, Emily Kowalski, Hyon K. Choi, Yuqing Zhang, Jeffrey A. Sparks, Zachary S. Wallace |
| 34 |
[GO] |
2022―Dez―15 |
COVID-19 and IgA Vasculitis |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 35 |
[GO] |
2022―Dez―15 |
B-cell reconstitution is associated with COVID-19 booster vaccine responsiveness in previously seronegative rituximab treated patients |
Kaitlin Schultz, Deanna Jannat-Khah, Robert Spiera |
| 36 |
[GO] |
2022―Dez―15 |
COVID-19 Disrupts Rheumatology Care: An Opportunity for Innovation? |
Rebecca Grainger, Valerie Milne |
| 37 |
[GO] |
2022―Dez―15 |
Oral antiviral treatment for COVID-19 in patients with systemic autoimmune rheumatic diseases |
Nafsika Gerolymatou, Athanasios-Dimitrios Bakasis, Paraskevi V. Voulgari, Panayiotis G. Vlachoyiannopoulos |
| 38 |
[GO] |
2022―Dez―15 |
COVID-19 vaccination perceptions in rheumatology patients: a cross-sectional online survey |
Imama Noor Butt, Charmaine van Eeden, Katharina Kovacs Burns, Lynora Saxinger, Alison Clifford, Jan Willem Cohen Tervaert, Elaine Yacyshyn |
| 39 |
[GO] |
2022―Dez―01 |
Impact Factor Jumps After the 2020 COVID-19 Pandemic: A Retrospective Study in Rheumatology Journals |
Abril-Carolina Mendoza-Lopez, Leslie-Marisol Gonzalez-Hermosillo, Ernesto Roldan-Valadez |
| 40 |
[GO] |
2022―Nov―15 |
COVID-19 vaccination as a trigger of IgA vasculitis: a global pharmacovigilance study |
Yanis Ramdani, Bérenger Largeau, Annie-Pierre Jonville-Bera, François Maillot, Alexandra Audemard-Verger |
| 41 |
[GO] |
2022―Nov―15 |
Prevalence, risk factors, and outcomes of gout flare in patients hospitalized for PCR-confirmed COVID-19: A multicenter retrospective cohort study |
Kanon Jatuworapruk, Panchalee Satpanich, Philip C. Robinson, Rebecca Grainger |
| 42 |
[GO] |
2022―Nov―01 |
IgA vasculitis following COVID-19 vaccination: A French multicentre case series including 12 patients |
Yanis Ramdani, Thomas Bettuzzi, Amel Bouznad, Léa Delaitre, Kladoum Nassarmadji, Kevin Didier, Carle Paul, Eric Liozon, Ashley Tieu, Gaëlle Richard-Colmant, Benjamin Terrier, Guillaume Moulis, Margaux Lafaurie, Evangeline Pillebout, François Maillot, Alexandra Audemard-Verger |
| 43 |
[GO] |
2022―Okt―15 |
The Third Dose Is the Charm: Effective Cellular and Humoral Immune Responses to Third COVID-19 Vaccine Doses in Immunosuppressed Nonresponders |
Wilson Kuswanto, Matthew C. Baker |
| 44 |
[GO] |
2022―Okt―01 |
Trend in industry payments to rheumatologists in the United States during the COVID-19 pandemic between 2013 and 2021 |
Anju Murayama, Sae Kamamoto, Kenichi Higuchi, Haruki Shigeta, Akihiko Ozaki |
| 45 |
[GO] |
2022―Okt―01 |
Changes in service delivery and access to rheumatologists pre- and during the COVID-19 pandemic in a Canadian universal healthcare setting |
Timothy S.H. Kwok, Bindee Kuriya, Lauren K King, Lihi Eder, Carter Thorne, Zhiyin Li, Therese Stukel, Longdi Fu, Alexander Kopp, Jessica Widdifield |
| 46 |
[GO] |
2022―Okt―01 |
Livedo reticularis after COVID-19 vaccination |
Taro Horino, Satoshi Inotani, Kimiko Nakajima, Yoshio Terada |
| 47 |
[GO] |
2022―Okt―01 |
Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines |
Carolina A. Isnardi, Osvaldo L. Cerda, Margarita Landi, Leonel Cruces, Emilce E. Schneeberger, Claudia Calle Montoro, María Agustina Alfaro, Brian M. Roldán, Andrea B. Gómez Vara, Pamela Giorgis, Roberto Alejandro Ezquer, María G. Crespo Rocha, Camila R. Reyes Gómez, Mária de los Ángeles Correa, Marcos G. Rosemffet, Virginia Carrizo Abarza, Santiago Catalan Pellet, Miguel Perandones, Cecilia Reimundes, Yesica Longueira, Gabriela Turk, María Florencia Quiroga, Natalia Laufer, Rosana Quintana, María Celina de la Vega, Nicolás Kreplak, Marina Pifano, Pablo Maid, Guillermo J. Pons-Estel, Gustavo Citera |
| 48 |
[GO] |
2022―Sep―01 |
IgA vasculitis following COVID-19: a French multicentric case-series |
Yanis Ramdani, Jean-Marc Galempoix, Jean François Augusto, Eva Dekmeer, Laurent Perard, Nicole Ferreira, Adrien Bigot, Julie Magnant, Stéphanie Jobard, Elisabeth Diot, Marie Charlotte Besse, Hélène Henique, François Maillot, Alexandra Audemard-Verger |
| 49 |
[GO] |
2022―Sep―01 |
From Canadian Living Guidelines to Global Living Guidelines: A Post Pandemic Effort |
Ines Colmenga, Michael E. Weinblatt |
| 50 |
[GO] |
2022―Aug―15 |
Adult-Onset Still Disease After ChadOx1 nCOV-19 Vaccination |
Jian Weng, Linghong Linda Zhou, Thomas Hahn, Kamran Shojania, Jan Dutz |
| 51 |
[GO] |
2022―Aug―01 |
Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association? |
Anastasios Karamanakos, Gerasimos Evangelatos, Maria Pappa, Kalliopi Fragiadaki, Antonis Fanouriakis, George E. Fragoulis |
| 52 |
[GO] |
2022―Jul―01 |
COVID-19 vaccine uptake among patients with systemic lupus erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN) |
Baptiste Chevet, Gabriel Figueroa-Parra, Jeffrey X. Yang, Cassondra A. Hulshizer, Tina M. Gunderson, Stephanie Q. Duong, Michael S. Putman, Kamil E. Barbour, Cynthia S. Crowson, Alí Duarte-García |
| 53 |
[GO] |
2022―Jun―15 |
Anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease after vaccination with COVID-19 mRNA vaccines |
Takamasa Kitajima, Atsushi Funauchi, Toshiki Nakajima, Satoshi Marumo, Yoshitaka Imura, Motonari Fukui |
| 54 |
[GO] |
2022―Jun―15 |
Evaluation of patients with rheumatoid arthritis in teleconsultation during the first wave of the COVID-19 pandemic |
Jérôme Avouac, Anna Molto, Camélia Frantz, Sarah Wanono, Elise Descamps, Olivier Fogel, Alice Combier, Lucile Poiroux, Corinne Miceli-Richard, Yannick Allanore |
| 55 |
[GO] |
2022―Jun―15 |
Long-term behavioral changes during the COVID-19 pandemic and impact of vaccination in patients with inflammatory rheumatic diseases |
Bente Glintborg, Dorte Vendelbo Jensen, Lene Terslev, Oliver Hendricks, Mikkel Østergaard, Simon Horskjær Rasmussen, Mogens Pfeiffer Jensen, Thomas Adelsten, Ada Colic, Kamilla Danebod, Malene Kildemand, Anne Gitte Loft, Heide Lausten Munk, Jens Kristian Pedersen, René Drage Østgård, Christian Møller Sørensen, Niels Steen Krogh, Jette Nørgaard Agerbo, Connie Ziegler, Merete Lund Hetland |
| 56 |
[GO] |
2022―Apr―15 |
Post SARS-CoV-2 Vaccine Chilblains-like Lesions |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 57 |
[GO] |
2022―Mrz―01 |
Time since rituximab treatment is essential for developing a humoral response to COVID-19 mRNA vaccines in patients with rheumatic diseases |
Anne Troldborg, Marianne Kragh Thomsen, Lars Erik Bartels, Jakob Bøgh Andersen, Signe Risbøl Vils, Clara Elbæk Mistegaard, Anders Dahl Johannsen, Marie-Louise From Hermansen, Susan Mikkelsen, Christian Erikstrup, Ellen-Margrethe Hauge, Christian Ammitzbøll |
| 58 |
[GO] |
2022―Mrz―01 |
COVID-19 Update for the GRAPPA 2021 Annual Meeting: Focus on COVID-19 Vaccination |
Philip J. Mease, Kevin Winthrop, Wendy Olsder, Jeffrey R. Curtis |
| 59 |
[GO] |
2022―Mrz―01 |
Immunogenicity of COVID-19 vaccination in patients with ankylosing spondylitis: a monocentric prospective belgian cohort study |
Tracy Vandergraesen, Leila Mekkaoui, Hafid Dahma, Muhammad Soyfoo, Laure Tant |
| 60 |
[GO] |
2022―Feb―01 |
Telemedicine Use During the COVID-19 Pandemic by Resilient Rheumatology Providers: A National Veterans Affairs Follow-up Survey |
Jasvinder A. Singh, John S. Richards, Elizabeth Chang, Amy M. Joseph, Bernard Ng |
| 61 |
[GO] |
2022―Feb―01 |
Impaired humoral immunogenicity of SARS-CoV-2 vaccination in rheumatoid arthritis patients |
Camille Le Moine, Muhammad Shahnawaz Soyfoo, Leila Mekkaoui, Hafid Dahma, Laure Tant |
| 62 |
[GO] |
2022―Feb―01 |
COVID-19 hospitalizations, intensive care unit stays, ventilation and death among patients with immune mediated inflammatory diseases compared to controls |
Lihi Eder, Ruth Croxford, Aaron M. Drucker, Arielle Mendel, Bindee Kuriya, Zahi Touma, Sindhu R. Johnson, Richard Cook, Sasha Bernatsky, Nigil Haroon, Jessica Widdifield |
| 63 |
[GO] |
2022―Jan―15 |
COVID-19 Vaccination Uptake among individuals with Immune-Mediated Inflammatory Diseases in Ontario, Canada between December 2020 and October 2021: A population-based analysis |
Jessica Widdifield, Lihi Eder, Simon Chen, Jeffrey C. Kwong, Carol Hitchon, Diane Lacaille, J. Antonio Aviña-Zubieta, Lawrence W. Svenson, Sasha Bernatsky |
| 64 |
[GO] |
2022―Jan―15 |
Safety profile and low risk of disease relapse after BNT162b2 mRNA SARS-COV-2 vaccination in patients with rare rheumatic diseases |
Marco Fornaro, Vincenzo Venerito, Florenzo Iannone, Fabio Cacciapaglia |
| 65 |
[GO] |
2021―Dez―15 |
Vasculitis As Temporally Associated With COVID-19 Infection or Vaccination: A Single-center Experience |
Alojzija Hočevar, Zoran Simonović, Žiga Rotar, Matija Tomšič |
| 66 |
[GO] |
2021―Nov―15 |
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients with Autoimmune Conditions Treated with Systemic Therapies: a Population-based Study |
Jeffrey R. Curtis, Xiaofeng Zhou, David T. Rubin, Walter Reinisch, Jinoos Yazdany, Philip C. Robinson, Yan Chen, Birgitta Benda, Ann Madsen, Jamie Geier |
| 67 |
[GO] |
2021―Nov―01 |
COVID-19 in Children With Rheumatic Diseases in the Spanish National Cohort EPICO-AEP |
Cristina Calvo, Clara Udaondo |
| 68 |
[GO] |
2021―Okt―15 |
The Effect of COVID-19 Illness on Pregnant Patients With Rheumatic Disease: Early Reassuring Data |
Lisa R. Sammaritano |
| 69 |
[GO] |
2021―Okt―15 |
Impact of COVID-19 pandemic on appropriateness of diagnostic pathways of autoimmune diseases |
Teresa Carbone, Valentina Picerno, Vito Pafundi, Ernesto Esposito, Pietro Leccese, Angela Padula, Salvatore D'Angelo |
| 70 |
[GO] |
2021―Okt―15 |
Improving COVID-19 vaccine coverage in patients with autoimmune and inflammatory diseases |
Tiphaine Goulenok, Chrystelle Francois, Céline Mendes, Fatima Farhi, Jean-Francois Alexandra, Diane Rouzaud, Thomas Papo, Karim Sacre |
| 71 |
[GO] |
2021―Okt―01 |
The Interplay between Covid-19 and Spondyloarthritis or Its Treatment |
James T. Rosenbaum, Michael H. Weisman, Hedley Hamilton, Cassie Shafer, Elin Aslanyan, Richard A. Howard, Kimberly Ogle, John D. Reveille, Kevin L. Winthrop, Dongseok Choi |
| 72 |
[GO] |
2021―Okt―01 |
Case of Giant Cell Arteritis After SARS-CoV-2 Vaccination: A Particular Phenotype? |
Agathe Sauret, Julien Stievenart, Perrine Smets, Louis Olagne, Benedicte Guelon, Olivier Aumaître, Marc André, Ludovic Trefond |
| 73 |
[GO] |
2021―Sep―01 |
COVID-19 in women with rheumatic disease who are pregnant: Data from the COVID-19 Global Rheumatology Alliance |
Bonnie L. Bermas, Milena Gianfrancesco, Helen L. Tanner, Andrea M. Seet, Mathia C. Aguiar, Nasra K. Al Adhoubi, Samar Al Emadi, Bernardo M. Cunha, Rachael Flood, Daria A. Kusevich, Eoghan M. McCarthy, Naomi J. Patel, Eric Ruderman, Sebastian E. Sattui, Savino Sciascia, Faizah Siddique, Mario O. Valenzuela-Almada, Leanna M. Wise, Angus B. Worthing, JoAnn Zell, Suleman Bhana, Wendy Costello, Ali Duarte-Garcia, Rebecca Grainger, Laure Gossec, Jonathan S. Hausmann, Kimme Hyrich, Saskia Lawson-Tovey, Jean W. Liew, Emily Sirotich, Jeffrey Sparks, Paul Sufka, Zachary Wallace, Pedro M. Machado, Anja Strangfeld, Megan E.B. Clowse, Jinoos Yazdany, Philip C. Robinson |
| 74 |
[GO] |
2021―Aug―01 |
The COVID-19 Pandemic and Rheumatology: Impact on Providing Care in Latin America and Around the World |
Sebastian E. Sattui, Philip C. Robinson |
| 75 |
[GO] |
2021―Jul―01 |
A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine? |
Alexa Simon Meara, Molly Silkoski,, Kai Quin, Wael Jarjour |
| 76 |
[GO] |
2021―Jun―15 |
Impact of COVID-19 pandemic on rheumatology practice in Latin America |
Daniel G. Fernández-Ávila, Julián Barahona-Correa, Diana Romero-Alvernia, Sergio Kowalski, Ana Sapag, Antonio Cachafeiro-Vilar, Belia Meléndez, Carlos Pastelín, Daniel Palleiro, Dina Arrieta, Gil Reyes, Guillermo J. Pons-Estel, Jossiell Then-Báez, Manuel F. Ugarte-Gil, Mario H. Cardiel, Nelly Colman, Nilmo Chávez, Paula I. Burgos, Rubén Montufar, Sayonara Sandino, Yurilis J. Fuentes-Silva, Enrique R. Soriano |
| 77 |
[GO] |
2021―Jun―01 |
The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know |
Katie Bechman, Mrinalini Dey, Mark Yates, Marwan Bukhari, Kevin Winthrop, James B. Galloway |
| 78 |
[GO] |
2021―Mai―15 |
Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases |
Glen S. Hazlewood, Jordi Pardo, Cheryl Barnabe, Orit Schieir, Claire E.H. Barber, Sasha Bernatsky, Ines Colmegna, Carol Hitchon, Mark Loeb, Dominik Mertz, Laurie Proulx, Dawn P. Richards, Rosie Scuccimarri, Peter Tugwell, Holger J. Schünemann, Reza D. Mirza, Alan L. Zhou, Roko P.A. Nikolic, Megan Thomas, Helena Chase, Maede Ejaredar, Robby Nieuwlaat |
| 79 |
[GO] |
2021―Mrz―15 |
Risk of severe coronavirus infection (COVID-19) in patients with inflammatory rheumatic diseases. |
Javier Bachiller-Corral, Alina Boteanu, Maria Jesus Garcia-Villanueva, Carlos de la Puente, Marcelino Revenga, M. Consuelo Diaz-Miguel, Ana Rodriguez-Garcia, Jose Luis Morell-Hita, Marta Valero, Carmen Larena, Maria Blazquez-Cañamero, Carlos A. Guillen-Astete, Sandra Garrote, Cristina Sobrino, Carmen Medina-Quiñones, Mónica Vazquez-Diaz |
| 80 |
[GO] |
2021―Mrz―15 |
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting |
Philip J. Mease, Leonard H. Calabrese, Kristina Callis Duffin, Rebecca H. Haberman, Rodrigo Firmino, Jose U. Scher, Lori Schick, Kevin Winthrop, Joseph F. Merola |
| 81 |
[GO] |
2021―Mrz―01 |
COVID-19 and Rheumatic Diseases: It Is Time to Better Understand This Association |
Claudia D.L. Marques |
| 82 |
[GO] |
2021―Feb―15 |
Re-thinking Physical Activity Promotion during COVID-19 Pandemic: Focus on a 24-hour Day |
Linda C. Li, Lynne M. Feehan, Alison M. Hoens |
| 83 |
[GO] |
2021―Feb―01 |
Covid-19 in Children with Rheumatic Diseases in the Spanish National Cohort EPICO-AEP |
Cristina Calvo, Clara Udaondo |
| 84 |
[GO] |
2020―Dez―01 |
Infection or autoimmunity? The clinical challenge of interstitial lung disease in systemic sclerosis during COVID 19 pandemic |
Martina Orlandi, Nicholas Landini, Cosimo Bruni, Stefano Colagrande, Marco Matucci-Cerinic, Musataka Kuwana |
| 85 |
[GO] |
2020―Nov―15 |
Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic |
Michael George, Shilpa Venkatachalam, Shubhasree Banerjee, Joshua F. Baker, Peter A. Merkel, Kelly Gavigan, David Curtis, Maria I. Danila, Jeffrey R. Curtis, W. Benjamin Nowell |
| 86 |
[GO] |
2020―Nov―01 |
Risk of Adverse Outcomes in Hospitalized Patients with Autoimmune Disease and COVID-19: A Matched Cohort Study from New York City |
Adam S. Faye, Kate E. Lee, Monika Laszkowska, Judith Kim, John William Blackett, Anna S. McKenney, Anna Krigel, Jon T. Gile, Runsheng Wang, Elana J. Bernstein, Peter H.R. Green, Suneeta Krishnareddy, Chin Hur, Benjamin Lebwohl |
| 87 |
[GO] |
2020―Okt―15 |
The Effect of HLA-B27 on Susceptibility and Severity of COVID-19 |
James T. Rosenbaum, Hedley Hamilton, Michael H. Weisman, John D. Reveille, Kevin L. Winthrop, Dongseok Choi |
| 88 |
[GO] |
2020―Okt―15 |
Giant Cell Arteritis and COVID-19: Similarities and Discriminators. A Systematic Literature Review |
Puja Mehta, Sebastian E. Sattui, Kornelis S.M. van der Geest, Elisabeth Brouwer, Richard Conway, Michael S. Putman, Philip C. Robinson, Sarah L. Mackie |
| 89 |
[GO] |
2020―Sep―15 |
Covid-19 in Patients with Connective Tissue Disease-Related Interstitial Lung Disease |
Linh Troung, Lila Pourzand, Elizabeth R. Volkmann |
| 90 |
[GO] |
2020―Sep―15 |
Attitudes and Behaviours of Patients with Rheumatic Diseases during the early stages of the COVID-19 Outbreak. |
Margaret H.Y. Ma, Sen Hee Tay, Peter P.M. Cheung, Amelia Santosa, Yiong Huak Chan, James W.L. Yip, Anselm Mak, Manjari Lahiri |
| 91 |
[GO] |
2020―Aug―15 |
Walk at least 10 minutes a day for adults with knee OA: Recommendation for minimal activity during the COVID-19 pandemic |
Jason T. Jakiela, Esther J. Waugh, Daniel K. White |
| 92 |
[GO] |
2020―Jul―01 |
Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in synovial tissues |
Sho Mokuda, Tadahiro Tokunaga, Junya Masumoto, Eiji Sugiyama |
| 93 |
[GO] |
2020―Jun―08 |
Rheumatologists and Pulmonologists at Temple University weather the COVID-19 storm together |
Roberto Caricchio, Gerard J. Criner |
| 94 |
[GO] |
2020―Jun―08 |
Teamwork, A Novel Concept During an Infectious Pandemic? |
Randy Q. Cron, W. Winn Chatham |
| 95 |
[GO] |
2020―Jun―01 |
No SLE with COVID-19 in Hong Kong: the effect of masking? |
Ho So, Joyce Wing Yan Mak, Lai-shan Tam |
| 96 |
[GO] |
2020―Jun―01 |
Are patients with systemic lupus erythematosus at increased risk of severe COVID-19? |
Ennio Giulio Favalli, Elena Agape, Roberto Caporali |
| 97 |
[GO] |
2020―Mai―25 |
Evidence of protective effect of hydroxychloroquine to prevent COVID-19 |
Beuy Joob, Viroj Wiwanitkit |
| 98 |
[GO] |
2020―Mai―25 |
Treating Covid-19 at the Inflection Point |
W. Winn Chatham, Randy Q. Cron |
| 99 |
[GO] |
2020―Mai―25 |
SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets - What to learn from Rheumatologists? |
Carlos Antonio Mouraa, Ana Luísa Cerqueira de Sant’Ana Costa |
| 100 |
[GO] |
2020―Mai―18 |
COVID-19 and Rheumatology patients on immunomodulatory therapy - can we extrapolate data from previous viral pandemics? |
Hannah Jethwa, Ann Sullivan, Sonya Abraham |
| 101 |
[GO] |
2020―Mai―11 |
Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials |
Stephen J. Balevic, Christoph P. Hornik, Thomas P. Green, Megan E.B. Clowse, Daniel Gonzalez, Anil R. Maharaj, Laura E. Schanberg, Amanda M. Eudy, Geeta K. Swamy, Brenna L. Hughes, Michael Cohen-Wolkowiez |
| 102 |
[GO] |
2020―Apr―25 |
Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis |
Ennio Giulio Favalli, Elena Agape, Roberto Caporali |
| 103 |
[GO] |
2020―Apr―25 |
The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic |
Randy Q. Cron, W. Winn Chatham |
| 104 |
[GO] |
2020―Apr―25 |
Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs |
Giovanni Filocamo, Francesca Minoia, Simone Carbogno, Stefania Costi, Micol Romano, Rolando Cimaz |
| 105 |
[GO] |
2020―Apr―08 |
Learning from Adversity: Lessons from the COVID-19 Crisis |
Michael S. Putman, Eric M. Ruderman |
| 106 |
[GO] |
2020―Apr―08 |
Possible Consequences of a Shortage of Hydroxychloroquine for Lupus Patients Amid the COVID-19 Pandemic |
Christine A. Peschken |
| 107 |
[GO] |
2020―Apr―02 |
Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic |
Rosie Scuccimarri, Evelyn Sutton, Mary-Ann Fitzcharles |
| 108 |
[GO] |
2020―Mrz―24 |
The Rheumatologist’s Role in Covid-19 |
Randy Q. Cron, W. Winn Chatham |
|
